BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ATH-063 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ATH-063\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07513181-24@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20281214
DTEND;VALUE=DATE:20281215
SUMMARY:ATH-063: Phase 2 readout est. (NCT07513181)
DESCRIPTION:ATH-063\, phase 2\, Ulcerative Colitis.\nStudy: Proof of Concep
 t Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patient
 s With Relapsed/Refractory Moderately to Severely Active Ulcerative Coliti
 s (UC)\nEstimated primary completion: 14 December 2028. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/ath-063#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT07513181
URL:https://assetmemo.bio/drug/ath-063#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
